Fentolamin,
Mesilate, Phentolamine,
Mesylate, Phentolamine,
Methanesulfonate, Phentolamine,
Mono-hydrochloride, Phentolamine,
Phentolamine,
Phentolamine Mesilate,
Phentolamine Mesylate,
Phentolamine Methanesulfonate,
Phentolamine Mono hydrochloride,
Phentolamine Mono-hydrochloride,
Regitine,
Regityn,
Rogitine,
Z-Max,
Phentolamine mesylate,
65-28-1,
phentolamine mesilate,
Phentolamine methanesulfonate,
Regitine mesylate,
OraVerse,
Phentolamine (mesylate),
Regitin methanesulphonate,
Regitine methanesulfonate,
Phentolamine mesylate [USP],
Phentolamine methanesulphonate,
UNII-Y7543E5K9T,
CCRIS 9022,
Phentolamine mesilate [INN:BAN],
EINECS 200-604-6,
MLS000069487,
Phentolamine methanesulfonate salt,
Y7543E5K9T,
Phentolamine mesylate [USAN],
MFCD00134201,
SMR000059054,
m-(N-(2-Imidazolin-2-ylmethyl)-p-toluidino)phenol monomethanesulfonate (salt),
Phentolamine mesylate (USP),
Phenol, 3-(((4,5-dihydro-1H-imidazol-2-yl)methyl)(4-methylphenyl)amino)-, monomethanesulfonate (salt),
C18H23N3O4S,
Phentolamine, methyl sulfonate,
3-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol; methanesulfonic acid,
Phenol, m-(N-(2-imidazolin-2-ylmethyl)-p-toluidino)-, monomethanesulfonate (salt),
Vasofem,
Vasomax,
Regitin mesylate,
SR-01000000055,
C17H19N3O.CH4O3S,
3-(((4,5-dihydro-1H-imidazol-2-yl)methyl)(p-tolyl)amino)phenol methanesulfonate,
3-[4,5-dihydro-1H-imidazol-2-ylmethyl-(4-methylphenyl)amino]phenol; methanesulfonic acid,
Regitine (TN),
phentolamine-mesilate,
Z-Max,
3-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol;methanesulfonic acid,
Opera_ID_1599,
Lopac-P-7561,
Phentolamine Meslate,(S),
SCHEMBL40852,
MLS001076484,
REGID_for_CID_91430,
AC1L3M27,
CHEMBL1200873,
CTK8G2357,
HY-B0362A,
KS-00000XQY,
DTXSID60215315,
Phentolamine mesilate (JAN/INN),
HMS2233A24,
HMS3263E05,
HMS3373D03,
HMS3655B13,
BCP09845,
Tox21_500982,
NV-101,
s2038,
AKOS007930193,
AC-7472,
AN-8957,
CCG-222286,
CS-2419,
LP00982,
MCULE-3770473461,
VZ33629,
NCGC00016195-01,
NCGC00016195-02,
NCGC00094282-01,
NCGC00261667-01,
4CA-1013,
AS-13800,
BC200362,
CPD000059054,
K062,
SAM002703130,
ST057364,
AB0014005,
AB2000443,
LS-104726,
EU-0100982,
FT-0603267,
P1985,
SW196637-3,
D00509,
J10339,
P 7561,
134P201,
A828197,
A835046,
I14-0396,
SR-01000000055-3,
W-104799,
Phentolamine methanesulfonate salt, >=98% (TLC), powder,
3-[N-(2-Imidazolin-2-ylmethyl)-p-toluidino]phenol methanesulphonate,
Phentolamine mesilate, British Pharmacopoeia (BP) Reference Standard,
2-[N-(m-Hydroxyphenyl)-p-toluidinomethyl]imidazoline Methanesulfonate,
2-[N-(m-Hydroxyphenyl)-p-toluidinomethyl]imidazoline, methanesulfonate,
Phentolamine mesilate, European Pharmacopoeia (EP) Reference Standard,
Phentolamine mesylate, United States Pharmacopeia (USP) Reference Standard,
3-[(2-imidazolin-2-ylmethyl)(4-methylphenyl)amino]phenol, methanesulfonic acid,
3-[[(4,5-Dihydro-1H-imidazol-2- yl)methyl](4-methylphenyl)-amino]phenol mesylate,
3-[[(4,5-Dihydro-1H-imidazol-2-yl)methyl](4-methylphenyl)-amino]phenol mesylate,
3-[[(4,5-Dihydro-1H-imidazol-2-yl)methyl](4-methylphenyl)amino]phenol methanesulfonate,
3-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methyl-anilino]phenol; methanesulfonic acid,
Phentolamine mesilate for system suitability, European Pharmacopoeia (EP) Reference Standard,
Phentolamine Mesylate, Pharmaceutical Secondary Standard; Certified Reference Material,
2-[N-(m-Hydroxyphenyl)-p-toluidinomethyl]imidazoline Methanesulfonate / Phentolamine Methanesulfonate,
Phenol,3-[[(4,5-dihydro-1H-imidazol-2-yl)methyl](4-methylphenyl)amino]-,monomethanesulfonate (salt),
Regitine,
Regitin,
phentolamine,
phentolaminmesilat-,
CID91430,
ACN-037025,
C17-H19-N3-O.C-H4-O3-S,
B1363,
A11734,
2-(N-[m-Hydroxyphenyl]-p-toluidinomethyl)imidazoline,
50-60-2,
Phentolamine methanesulfonate salt, 98%, a nonselective alpha-adrenergic antagonist - 1G 1g,
Phenol, 3-[[(4,5-dihydro-1H-imidazol-2-yl)methyl](4-methylphenyl)amino]-, monomethanesulfonate (salt),